Inovio Pharmaceuticals Inc. (INO) shares are trading at lower $11.99 and the avg recommendation for the stock is Moderate Buy. while the current analyst price target stands at $19.00.
To add more color to this target, the company’s high over the last year is $33.79 and the low is $1.91. Over the last 52 weeks, INO is up 455.09% while the S&P 500 is up 19.44%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
In the last quarter, INO reported a profit of $33.45 million. Inovio Pharmaceuticals Inc. also saw revenues increase to $0.27 million. In addition, INO has free cash flow of -$52.78 million as of 06-2020. The company’s EBITDA came in at -$32.52 million which compares well with its peers.
FREE CONFIDENTIAL REPORT
3 Stocks Set To Soar By January 1st, 2021
You have Successfully Subscribed!
INO Return on Equity (ROE) is -217.80%, and its Return on Assets is -82.40%. All told, it is clear that, INO needs to be on your watchlist.
Find out when INO reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. INO has a short ratio of 1.48 and outstanding shares of 167.52M.
INO has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 11.99 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.70. Inovio Pharmaceuticals Inc. INO also noted assets of $443.19 million at the end of the last quarter. Investors should also keep an eye on sector updates as INO has historically followed its peers on positive news.
All told, Inovio Pharmaceuticals Inc. INO has strung together solid data and demonstrated underlying fundamentals. At its current valuation, INO represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
Inovio Pharmaceuticals Inc. INO is now commanding a market cap of 1.97B and a float of 164.19M. INO is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of INO stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in INO, either long or short, and we have not been compensated for this article.